REQUEST A DEMO
Total
USD $0.00
Search more companies

PuraPharm Corporation Limited (Hong Kong) (Hong Kong SAR, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: PuraPharm Corporation Limited Profile Updated: March 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

PuraPharm Corporation Limited is a company dedicated to the modernization and internationalization of traditional Chinese medicine (TCM). The Company is engaged in the research and development, manufacturing, marketing and selling, quality control and basic science research of concentrated Chinese Medicine granules (CCMG) products which the Company markets under their brand “Nong’s®. PuraPharm has also developed a series of over-the-counter health products, among which, brands such as PuraGold®, Oncozac® and Haveron®. The Company was incorporated in 1998 and is headquartered in Hong Kong.

Headquarters
Suite 4002, Jardine House, 1 Connaught Place
Hong Kong; Hong Kong;

Contact Details: Purchase the PuraPharm Corporation Limited (Hong Kong) report to view the information.

Website: http://www.purapharm.com

Basic Information
Total Employees:
Purchase the PuraPharm Corporation Limited (Hong Kong) report to view the information.
Outstanding Shares:
Purchase the PuraPharm Corporation Limited (Hong Kong) report to view the information.
Registered Capital:
Purchase the PuraPharm Corporation Limited (Hong Kong) report to view the information.
Financial Auditors:
Purchase the PuraPharm Corporation Limited (Hong Kong) report to view the information.
Incorporation Date:
2011
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Vice Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
20.69%
Purchase this report to view the information.
19.54%
Purchase this report to view the information.
19.54%
Subsidiaries
Purapharm Holdings Limited (United Kingdom)
100%
Company Performance
Financial values in the chart are available after PuraPharm Corporation Limited (Hong Kong) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HKD. Absolute financial data is included in the purchased report.
Net sales revenue
-15.46%
Total operating revenue
-13.13%
Operating profit (EBIT)
-14.92%
EBITDA
N/A
Net Profit (Loss) for the Period
5.58%
Total assets
-12.51%
Total equity
-38.89%
Operating Profit Margin (ROS)
-3.23%
Net Profit Margin
-2.02%
Return on Equity (ROE)
-6.15%
Debt to Equity Ratio
81.48%
Quick Ratio
-0.16%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?